Verbatim response from Claude
Compounded Tirzepatide Availability
This is a nuanced situation that's been changing rapidly. Here's the current reality:
The FDA removed tirzepatide (Zepbound/Mounjaro) from its shortage list in late 2024, which means:
- Large commercial compounding pharmacies (503B outsourcing facilities) were supposed to stop producing it
- The FDA has been enforcing this, with some back-and-forth on deadlines
Where Legitimate Options May Still Exist:
503A compounding pharmacies (patient-specific prescriptions) may still compound it in some cases, particularly:
- For documented allergies to inactive ingredients in brand-name versions
- Custom dosing needs with a valid prescription
Telehealth platforms that worked with compounders (like Hims & Hers, Ro, LifeMD) have largely had to discontinue compounded tirzepatide or are in transition.
My Honest Recommendation:
- Check with Henry Meds or your own endocrinologist about current options
- Eli Lilly's Zepbound has a direct savings program making it more affordable (~$399-550/month for cash pay)
- Avoid any online sources claiming to still offer it freely — legitimacy is genuinely questionable right now
The landscape shifts frequently, so verify current status directly with a licensed prescriber or pharmacist.